HUTCY yields 5.98% · PFE yields 6.13%● Live data
📍 HUTCY pulled ahead of the other in Year 1
Combined, HUTCY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HUTCY + PFE for your $10,000?
Hutchison Telecommunications Hong Kong Holdings Limited, an investment holding company, provides mobile communication services. It offers 5G, 4G long term evolution, 3G, and GSM dual-band mobile telecommunications under the 3 brand. The company also provides mobile telecommunications services and products include local voice, SMS, MMS, international direct dialing, and international roaming; and data services and applications, such as direct carrier billing offerings, mobile device security management, eBooks, music downloads, movies-on-demand, mobile social networking applications, and FinTech, as well as Wi-Fi and other value-added services. In addition, the company is involved in the provision of marketing, advertising, and promotional services; and telecommunications retail operations. As of December 31, 2021, it served approximately 3.2 million customers in Hong Kong and Macau. The company was incorporated in 2007 and is headquartered in Central, Hong Kong. Hutchison Telecommunications Hong Kong Holdings Limited is a subsidiary of CK Hutchison Holdings Limited.
Full HUTCY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.